Pretreatment prognostic factors for survival in patients with advanced urothelial tumors treated in a phase I/II trial with paclitaxel, cisplatin, and gemcitabine-Reference-Cited by-同舟云学术

Pretreatment prognostic factors for survival in patients with advanced urothelial tumors treated in a phase I/II trial with paclitaxel, cisplatin, and gemcitabine

Published:2002-07-31 Issue:4 Volume:95 Page:751-757
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Bellmunt Joaquim,Albanell Joan,Paz-Ares Luis,Climent Miguel A.,González-Larriba Jose L.,Carles Joan,de la Cruz Juan J.,Guillem Vicente,Díaz-Rubio Eduardo,Cortés-Funes Hernan,Baselga José

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference27 articles.

1. Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium;Sternberg;Cancer.,1989

2. Cisplatin, methotrexate, and vinblastine (CMV): an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract: a Northern California Oncology Group study;Harker;J Clin Oncol.,1985

3. M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) chemotherapy for transitional cell carcinoma: the Princess Margaret Hospital experience;Tannock;J Urol.,1989

4. Advanced bladder cancer: the need to identify new agents in the post-M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) world;Roth;J Urol.,1995

5. Long term follow-up of a Phase III Intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study;Saxman;J Clin Oncol.,1997

Cited by 132 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Objective Response Rate is a Surrogate Marker for Long-Term Overall Survival in Metastatic Urothelial Carcinoma Patients Treated With Immune Checkpoint Inhibitors;Clinical Genitourinary Cancer;2024-10

2. Neue Systemtherapie beim fortgeschrittenen Harnblasenkarzinom;Die Urologie;2024-08-29

3. Pre-first-line chemotherapy risk stratification for overall survival in advanced urothelial carcinoma in sequential therapy era;World Journal of Urology;2024-05-09

4. Latin American Consensus for the Evaluation and Treatment of Patients With Metastatic/Locally Advanced Urothelial Carcinoma;JCO Global Oncology;2024-02

5. Metastatic Organotropism Differential Treatment Response in Urothelial Carcinoma: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials;European Urology Oncology;2023-11